| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 116.109 | 317.181 | 437.825 | 508.406 |
| Total Income - EUR | - | - | - | - | - | - | 116.476 | 322.048 | 437.873 | 534.899 |
| Total Expenses - EUR | - | - | - | - | - | - | 108.504 | 284.181 | 380.833 | 490.302 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 7.972 | 37.867 | 57.040 | 44.597 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 6.829 | 34.695 | 52.968 | 36.143 |
| Employees | - | - | - | - | - | - | 2 | 4 | 3 | 3 |
Check the financial reports for the company - Lorena Anerol Phar S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 999 | 47.742 | 70.898 | 93.178 |
| Current Assets | - | - | - | - | - | - | 24.746 | 118.901 | 158.337 | 175.457 |
| Inventories | - | - | - | - | - | - | 22.352 | 77.108 | 95.972 | 94.392 |
| Receivables | - | - | - | - | - | - | 0 | 41.564 | 56.476 | 56.339 |
| Cash | - | - | - | - | - | - | 2.394 | 229 | 5.889 | 24.726 |
| Shareholders Funds | - | - | - | - | - | - | 6.870 | 41.586 | 60.223 | 43.126 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 18.875 | 125.057 | 169.012 | 227.710 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Lorena Anerol Phar S.r.l.